Michele M. Leonhart: Testimony Before the House of Representatives Committee on Oversight and Government Reform for a Hearing Examining the Office of Inspector General’s Report, “The Handling of Sexual Harassment and Misconduct Allegations by the Department’s Law Enforcement Components”

The threat posed by heroin in the United States is serious and has increased since 2007. Heroin is available in larger quantities, used by a larger number of people, and is causing an increasing number of overdose deaths. In 2013, 8,620 Americans died from heroin-related overdoses, nearly triple the number...

Barbra Roach: Before The Committee on Indian Affairs United States Senate for a Field Oversight Hearing Addressing the Harmful Effects of Dangerous Drugs in Native Communities

Michele M. Leonhart: Before The United States Senate Committee On Appropriations Subcommittee On Commerce, Justice, Science And Related Agencies

Enantiomeric Determination of Methamphetamine, Amphetamine, Ephedrine, and Pseudoephedrine using Chiral Supercritical Fluid Chromatography with Mass Spectrometric Detection. Microgram Journal 2015; 12(1-4):19-30.

Analysis of Marijuana by Liquid Chromatographic Techniques - A Literature Survey, 1990 – 2015. Microgram Journal 2015;12(1-4):1-17.

James Soiles: After Withdrawal: The Way Forward in Afghanistan and Pakistan (Part III)

Marijuana Concentrates—also known as “THC Extractions” (2014) is a six panel, two-sided pamphlet that provides information on the dangers of marijuana concentrates. The pamphlet also describes the common street names, how it is abused, and the dangers of converting marijuana into marijuana concentrates using the butane extraction process.

The threat from CPD abuse is persistent and deaths involving CPDs outnumber those involving heroin and cocaine combined. The economic cost of nonmedical use of prescription opioids alone in the United States totals more than $53 billion annually. Transnational Criminal Organizations (TCOs), street gangs, and other criminal groups, seeing the...

Michele M. Leonhart: Before the Subcommittee on Crime, Terrorism, Homeland Security and Investigations Committee on the Judiciary U.S. House of Representatives for a Hearing on Oversight of the Drug Enforcement Administration